Psychedelic assisted psychotherapy: The Australian landscape
On 3 February 2023, the Therapeutic Goods Administration (TGA) announced approval of the psychedelic substances in magic mushrooms and MDMA for use by people with certain mental health conditions, specifically PTSD and treatment resistant depression. This makes Australia the first country in the world to recognise psychedelics as medicines. In this interview, I explore the current psychedelic research in Australia with Martin Williams, PhD.
